315 related articles for article (PubMed ID: 19337803)
1. Effect of alendronate and intermittent parathyroid hormone on implant fixation in ovariectomized rats.
Skripitz R; Johansson HR; Ulrich SD; Werner A; Aspenberg P
J Orthop Sci; 2009 Mar; 14(2):138-43. PubMed ID: 19337803
[TBL] [Abstract][Full Text] [Related]
2. Effect of preoperative combined treatment with alendronate and calcitriol on fixation of hydroxyapatite-coated implants in ovariectomized rats.
Nakamura Y; Hayashi K; Abu-Ali S; Naito M; Fotovati A
J Bone Joint Surg Am; 2008 Apr; 90(4):824-32. PubMed ID: 18381321
[TBL] [Abstract][Full Text] [Related]
3. Intermittent administration of human parathyroid hormone (1-34) increases new bone formation on the interface of hydroxyapatitecoated titanium rods implanted into ovariectomized rat femora.
Ohkawa Y; Tokunaga K; Endo N
J Orthop Sci; 2008 Nov; 13(6):533-42. PubMed ID: 19089541
[TBL] [Abstract][Full Text] [Related]
4. The effects of combined human parathyroid hormone (1-34) and simvastatin treatment on osseous integration of hydroxyapatite-coated titanium implants in the femur of ovariectomized rats.
Tao ZS; Zhou WS; Tu KK; Huang ZL; Zhou Q; Sun T; Lv YX; Cui W; Yang L
Injury; 2015 Nov; 46(11):2164-9. PubMed ID: 26404665
[TBL] [Abstract][Full Text] [Related]
5. Effect of intermittent parathyroid hormone (1-34) treatment on the bone response after placement of titanium implants into the tibia of ovariectomized rats.
Shirota T; Tashiro M; Ohno K; Yamaguchi A
J Oral Maxillofac Surg; 2003 Apr; 61(4):471-80. PubMed ID: 12684966
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with ONO-KK1-300-01, a cathepsin K inhibitor, and parathyroid hormone results in additive beneficial effect on bone mineral density in ovariectomized rats.
Ochi Y; Yamada H; Mori H; Kawada N; Tanaka M; Imagawa A; Ohmoto K; Kawabata K
J Bone Miner Metab; 2016 Jan; 34(1):33-40. PubMed ID: 25762435
[TBL] [Abstract][Full Text] [Related]
7. PTH [1-34] enhances bone response around titanium implants in a rabbit model of osteoporosis.
Almagro MI; Roman-Blas JA; Bellido M; Castañeda S; Cortez R; Herrero-Beaumont G
Clin Oral Implants Res; 2013 Sep; 24(9):1027-34. PubMed ID: 22626278
[TBL] [Abstract][Full Text] [Related]
8. The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice.
Yamane H; Sakai A; Mori T; Tanaka S; Moridera K; Nakamura T
Bone; 2009 Jun; 44(6):1055-62. PubMed ID: 19303837
[TBL] [Abstract][Full Text] [Related]
9. Raloxifene enhances peri-implant bone healing in osteoporotic rats.
Ramalho-Ferreira G; Faverani LP; Prado FB; Garcia IR; Okamoto R
Int J Oral Maxillofac Surg; 2015 Jun; 44(6):798-805. PubMed ID: 25813087
[TBL] [Abstract][Full Text] [Related]
10. Intermittent administration of human parathyroid hormone (1-34) increases fixation of strontium-doped hydroxyapatite coating titanium implants via electrochemical deposition in ovariectomized rat femur.
Tao ZS; Zhou WS; Qiang Z; Tu KK; Huang ZL; Xu HM; Sun T; Lv YX; Cui W; Yang L
J Biomater Appl; 2016 Feb; 30(7):952-60. PubMed ID: 26482573
[TBL] [Abstract][Full Text] [Related]
11. Once-weekly parathyroid hormone combined with ongoing long-term alendronate treatment promotes osteoporotic fracture healing in ovariectomized rats.
Zhang C; Zhu J; Jia J; Guan Z; Sun T; Zhang W; Yuan W; Wang H; Leng H; Song C
J Orthop Res; 2021 Oct; 39(10):2103-2115. PubMed ID: 33325546
[TBL] [Abstract][Full Text] [Related]
12. [Effects of teriparatide and alendronate on bone mineral density of osteoporotic rats].
Li M; Jiao J; Meng XW; Xing XP; Xia WB; Zhou XY; Liu HC; Jiang Y; Wang O; Hu YY; Zhan ZW
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):335-8. PubMed ID: 15854512
[TBL] [Abstract][Full Text] [Related]
13. The bone architecture is enhanced with combined PTH and alendronate treatment compared to monotherapy while maintaining the state of surface mineralization in the OVX rat.
Campbell GM; Bernhardt R; Scharnweber D; Boyd SK
Bone; 2011 Aug; 49(2):225-32. PubMed ID: 21515436
[TBL] [Abstract][Full Text] [Related]
14. Effect of ovariectomy and alendronate on implant osseointegration in rat maxillary bone.
Viera-Negrón YE; Ruan WH; Winger JN; Hou X; Sharawy MM; Borke JL
J Oral Implantol; 2008; 34(2):76-82. PubMed ID: 18478902
[TBL] [Abstract][Full Text] [Related]
15. Effect of 17beta-estradiol and alendronate on the removal torque of osseointegrated titanium implants in ovariectomized rats.
Giro G; Sakakura CE; Gonçalves D; Pereira RM; Marcantonio E; Orrico SR
J Periodontol; 2007 Jul; 78(7):1316-21. PubMed ID: 17608587
[TBL] [Abstract][Full Text] [Related]
16. [Skeletal biomechanical properties improvement in ovariectomized osteoporotic rats of teriparatide was retarded by alendronate].
Li M; Jiao J; Meng XW; Zhou XY; Xing XP; Xia WB; Wang O; Jiang Y; Liu HC; Hu YY
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):104-7. PubMed ID: 16624115
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of implant fixation by parathyroid hormone (1-34)-A histomorphometric comparison of PMMA cement and stainless steel.
Skripitz R; Böhling S; Rüther W; Aspenberg P
J Orthop Res; 2005 Nov; 23(6):1266-70. PubMed ID: 15964166
[TBL] [Abstract][Full Text] [Related]
18. Intermittent Ibandronate Maintains Bone Mass, Bone Structure, and Biomechanical Strength of Trabecular and Cortical Bone After Discontinuation of Parathyroid Hormone Treatment in Ovariectomized Rats.
Takeda S; Sakai S; Tanaka K; Tomizawa H; Serizawa K; Yogo K; Urayama K; Hashimoto J; Endo K; Matsumoto Y
Calcif Tissue Int; 2017 Jul; 101(1):65-74. PubMed ID: 28246925
[TBL] [Abstract][Full Text] [Related]
19. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of Bone Augmentation in Osteoporotic Conditions by the Intermittent Parathyroid Hormone: An Animal Study in the Calvarium of Ovariectomized Rat.
Kubota T; Hasuike A; Naito M; Tsunori K; Min S; Sato S
Int J Oral Maxillofac Implants; 2018; 33(5):1003-1010. PubMed ID: 30231085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
